These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12530320)

  • 1. The role of chemokines in sepsis and septic shock.
    Murdoch C; Finn A
    Contrib Microbiol; 2003; 10():38-57. PubMed ID: 12530320
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock.
    Pruitt JH; Copeland EM; Moldawer LL
    Shock; 1995 Apr; 3(4):235-51. PubMed ID: 7600191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous mediators in sepsis and septic shock.
    Beishuizen A; Vermes I; Haanen C
    Adv Clin Chem; 1998; 33():55-131. PubMed ID: 10086175
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenomedullin in sepsis and septic shock.
    Wang P
    Shock; 1998 Nov; 10(5):383-4. PubMed ID: 9840656
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic derangements in sepsis and septic shock.
    Mizock BA
    Crit Care Clin; 2000 Apr; 16(2):319-36, vii. PubMed ID: 10768084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current advances in sepsis and septic shock with particular emphasis on the role of insulin.
    Das UN
    Med Sci Monit; 2003 Aug; 9(8):RA181-92. PubMed ID: 12942044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid administration in sepsis and septic shock: time for a paradigm change?
    Antonucci E; Fiaccadori E; Taccone FS; Vincent JL
    Minerva Anestesiol; 2014 Sep; 80(9):1058-62. PubMed ID: 24971687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural course of septic shock in a canine model. Cardiorespiratory and metabolic parameters.
    Yuan XQ; Wu ZG; He LJ; Cai ZH
    Chin Med J (Engl); 1984 Mar; 97(3):197-204. PubMed ID: 6432483
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemokines and interleukin-18 are up-regulated in bronchoalveolar lavage fluid but not in serum of septic surgical ICU patients.
    Mathiak G; Neville LF; Grass G; Boehm SA; Luebke T; Herzmann T; Kabir K; Rosendahl R; Schaefer U; Mueller C; Bohlen H; Wassermann K; Hoelscher AH
    Shock; 2001 Mar; 15(3):176-80. PubMed ID: 11236899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
    De Paepe P; Belpaire FM; Buylaert WA
    Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
    Varghese JM; Roberts JA; Lipman J
    Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in splenic and hepatic protein kinase C in sepsis and chronic endotoxemia.
    Hermiller JB; Deuciuc I; Mehegan JP; Spitzer JA; Roth BL
    Prog Clin Biol Res; 1989; 286():61-70. PubMed ID: 2928368
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytokines involved in human septic shock--the model of the Jarisch-Herxheimer reaction.
    Griffin GE
    J Antimicrob Chemother; 1998 Jan; 41 Suppl A():25-9. PubMed ID: 9511083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines and chemokines--their receptors and their genes: an overview.
    Cameron MJ; Kelvin DJ
    Adv Exp Med Biol; 2003; 520():8-32. PubMed ID: 12613570
    [No Abstract]   [Full Text] [Related]  

  • 15. Should high mobility group box-1 protein (HMGB1) be measured in patients with severe sepsis and septic shock? If so, when, where, and how?
    Eriksson M
    Crit Care Med; 2005 Mar; 33(3):682-3. PubMed ID: 15753771
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppressive Effects of Ginsenoside Rh1 on HMGB1-Mediated Septic Responses.
    Lee W; Cho SH; Kim JE; Lee C; Lee JH; Baek MC; Song GY; Bae JS
    Am J Chin Med; 2019; 47(1):119-133. PubMed ID: 30630344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans.
    Huber-Lang M; Sarma JV; Rittirsch D; Schreiber H; Weiss M; Flierl M; Younkin E; Schneider M; Suger-Wiedeck H; Gebhard F; McClintock SD; Neff T; Zetoune F; Bruckner U; Guo RF; Monk PN; Ward PA
    J Immunol; 2005 Jan; 174(2):1104-10. PubMed ID: 15634936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Kidney Tissue Barrier Disrupture and Renal Dysfunction in Resuscitated Murine Septic Shock.
    Stenzel T; Weidgang C; Wagner K; Wagner F; Gröger M; Weber S; Stahl B; Wachter U; Vogt J; Calzia E; Denk S; Georgieff M; Huber-Lang M; Radermacher P; McCook O
    Shock; 2016 Oct; 46(4):398-404. PubMed ID: 26926005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications.
    Wu A; Hinds CJ; Thiemermann C
    Shock; 2004 Mar; 21(3):210-21. PubMed ID: 14770033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's new in Shock? September 2014.
    Banerjee A
    Shock; 2014 Sep; 42(3):177-8. PubMed ID: 25122081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.